Andreas Betz is a Senior Scientist at Global Blood Therapeutics in South San Francisco, CA, with extensive experience in high-throughput screening, data analysis, and the development of functional assays for protease and kinase activities since June 2012. Previous roles include Consultant at Portola Pharmaceuticals focused on the analysis of clinical data, and Data Analyst at GlaxoSmithKline with expertise in data transfer and report production. Betz has held research positions at Novartis and Pharmacia, employing statistical analysis for enzyme characterization and assay development. Educational qualifications include a PhD in Biophysics from the University of Basel and a postdoctoral fellowship in Biochemistry from Emory University School of Medicine.
Org chart
Teams
This person is not in any teams
Offices
GBT
3 followers
Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities.
